KRAS and neoplasm: Ectopic expression of p16INK4A led to significantly reduced tumor growth induced by activated KRAS4BG12V (Figure 6A), emphasizing the tumor-suppressive role of upregulated p16INK4A in KRAS-driven hepatocarcinogenesis.